CST3 and acute kidney injury: A serum Cystatin C increase ≥10% from the baseline within 24 h (a cut-off value previously validated for AKI prediction) [21,22] was observed in 8/16 (50%) and 1/22 (5%) patients respectively for AKI and non-AKI groups at 10 h.